Edwards will produce components at the Shannon site





Edwards Lifesciences has confirmed that it has begun renovations to convert its existing Shannon plant into a manufacturing center to produce components that form an integral part of Edwards’ life-saving transcatheter heart valves.

“The expanded capacity of our Shannon plant demonstrates that our operations in Ireland are a key enabler for Edwards to continue to help patients around the world,” said Andrew Walls, Edwards’ managing director for its manufacturing facilities in Ireland.

Edwards established its operations in Shannon in 2018 and officially opened its factory in Limerick in October. Around this time, Edwards announced that it will employ up to 850 people in the region by 2025. The Limerick plant manufactures catheter therapies to repair or replace damaged heart valves, allowing patients to live longer and healthier.

Edwards Lifesciences is the global leader in patient-focused innovations for monitoring structural heart disease and critical care. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.







About the author